Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
Yingzhu Li, Rumiana Tenchov, Jeffrey Smoot, et al.
ACS Central Science (2021) Vol. 7, Iss. 4, pp. 512-533
Open Access | Times Cited: 316

Showing 1-25 of 316 citing articles:

Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Rumiana Tenchov, Robert E. Bird, Allison Curtze, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 16982-17015
Closed Access | Times Cited: 1278
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz X. Heinz, Karin Stiasny
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 339
Impact of COVID-19 pandemic on socio-economic, energy-environment and transport sector globally and sustainable development goal (SDG)
Srijita Nundy, Aritra Ghosh, Abdelhakim Mesloub, et al.
Journal of Cleaner Production (2021) Vol. 312, pp. 127705-127705
Open Access | Times Cited: 248
Cutaneous findings following COVID‐19 vaccination: review of world literature and own experience
Thilo Gambichler, Stefanie Boms, Laura Susok, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. 2, pp. 172-180
Open Access | Times Cited: 188
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
Andreas Luttens, Hjalmar Gullberg, Eldar Abdurakhmanov, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 7, pp. 2905-2920
Open Access | Times Cited: 181
Viral vector‐based gene therapies in the clinic
Zongmin Zhao, Aaron C. Anselmo, Samir Mitragotri
Bioengineering & Translational Medicine (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 176
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 166
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
Chunlong Ma, M. Sacco, Zilei Xia, et al.
ACS Central Science (2021) Vol. 7, Iss. 7, pp. 1245-1260
Open Access | Times Cited: 158
Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review
Debendra Nath Roy, Mohitosh Biswas, Md. Ekramul Islam, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0265496-e0265496
Open Access | Times Cited: 158
Fear of COVID-19 and its association with mental health-related factors: systematic review and meta-analysis
Zainab Alimoradi, Maurice M. Ohayon, Mark D. Griffiths, et al.
BJPsych Open (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 151
Lipid nanoparticles in the development of mRNA vaccines for COVID-19
Barnabas Wilson, K. Geetha
Journal of Drug Delivery Science and Technology (2022) Vol. 74, pp. 103553-103553
Open Access | Times Cited: 132
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease
Haozhou Tan, Yanmei Hu, Prakash D. Jadhav, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7561-7580
Open Access | Times Cited: 115
Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines
Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo
Molecular Pharmaceutics (2021) Vol. 18, Iss. 8, pp. 2867-2888
Open Access | Times Cited: 103
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Sachin S. Shivatare, Vidya S. Shivatare, Chi‐Huey Wong
Chemical Reviews (2022) Vol. 122, Iss. 20, pp. 15603-15671
Open Access | Times Cited: 103
Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models
Han-Yi Huang, Hsin-Yu Liao, Xiaorui Chen, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 639
Open Access | Times Cited: 99
A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, et al.
VirusDisease (2022) Vol. 33, Iss. 1, pp. 1-22
Open Access | Times Cited: 98
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance
Ala M. Shaqra, Sarah N. Zvornicanin, Qiu Yu J. Huang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 93
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
Bioconjugate Chemistry (2023) Vol. 34, Iss. 6, pp. 941-960
Open Access | Times Cited: 87
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 74
The Progress and Promise of RNA Medicine─An Arsenal of Targeted Treatments
Janet M. Sasso, Barbara J. B. Ambrose, Rumiana Tenchov, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 6975-7015
Open Access | Times Cited: 72
A Global Picture: Therapeutic Perspectives for COVID-19
Vivek P. Chavda, Carron Kapadia, Shailvi Soni, et al.
Immunotherapy (2022) Vol. 14, Iss. 5, pp. 351-371
Open Access | Times Cited: 71
Aptamer-Based Targeted Protein Degradation
Yuan Liu, Xu Qian, Chunyan Ran, et al.
ACS Nano (2023) Vol. 17, Iss. 7, pp. 6150-6164
Open Access | Times Cited: 44
COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
İlker Polatoğlu, Tülay Öncü Öner, Irem Dalman, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 43
An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 40
Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design
Lisa-Marie Funk, Gereon Poschmann, Fabian Rabe von Pappenheim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top